AKR1C1 human
SIGMA/SRP6087 - recombinant, expressed in E. coli, ≥90% (SDS-PAGE)
Synonym: 20-alpha HSD; Aldo-keto reductase family 1 member C1; DD1/DD2; DDH1; HBAB
CAS Number: 1527538-64-2
Product Type: Product-on-demand
Immunoblotting AKR1C1 Cat. No. SRP6087: SDS-PAGE of human recombinant AKR1C1.
| assay | ≥90% (SDS-PAGE) |
| biological source | human |
| form | liquid |
| mol wt | 38.9 kDa |
| NCBI accession no. | Q04828   |
| packaging | pkg of 100 μg |
| recombinant | expressed in E. coli |
| shipped in | dry ice |
| storage temp. | −70°C |
| Biochem/physiol Actions: | AKR1C (aldo-keto reductase 1C) family of proteins is responsible for maintaining steroid homeostasis, activation of polycyclic aromatic hydrocarbons and the metabolism of prostaglandin. These enzymes function as NAD(P)(H)-dependent oxidoreductases and are responsible for the production of alcohol by catalyzing the reduction of aldehydes and ketones. Studies show that up-regulation of AKR1C1 is linked with resistance to anti-cancer therapeutics such as, adriamycin, daunorubicin and cisplatin. In human endometrial tissues, this protein is responsible for the conversion of progesterone to a biologically inactive metabolite. Studies in cultured endometrial stromal cells show that the mRNA expression level of AKR1C1 is inversely dependent on the level of progesterone, thus suggesting that progesterone controls its own local concentration through AKR1C1 enzyme in endometrial stromal cells at peri-implantation periods. |
| General description: | AKR1C1 (aldo-keto reductase 1C1) is one of the four isoforms (AKR1C1–AKR1C4) of the phase I drug-metabolizing enzyme family called AKR1C. This enzyme is thought to be composed of 323 amino acids, and its mRNA is expressed in brain, mammary gland tissues, liver, adrenal, prostate, uterus and testis. |
| Other Notes: | MGSSHHHHHH SSGLVPRGSH MDSKYQCVKL NDGHFMPVLG FGTYAPAEVP KSKALEATKL AIEAGFRHID SAHLYNNEEQ VGLAIRSKIA DGSVKREDIF YTSKLWCNSH RPELVRPALE RSLKNLQLDY VDLYLIHFPV SVKPGEEVIP KDENGKILFD TVDLCATWEA VEKCKDAGLA KSIGVSNFNR RQLEMILNKP GLKYKPVCNQ VECHPYFNQR KLLDFCKSKD IVLVAYSALG SHREEPWVDP NSPVLLEDPV LCALAKKHKR TPALIALRYQ LQRGVVVLAK SYNEQRIRQN VQVFEFQLTS EEMKAIDGLN RNVRYLTLDI FAGPPNYPFS DEY |
| Physical form: | 0.5 mg/mL solution in 20 mM Tris-HCl buffer (pH 8.0) containing 1 mM DTT and 20% glycerol. |
| Preparation Note: | Centrifuge the vial prior to opening. |
| Symbol |  GHS07 |
| Signal word | Warning |
| Hazard statements | H319 |
| Precautionary statements | P264 - P280 - P305 + P351 + P338 - P337 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥90% (SDS-PAGE) |
| Storage Temp. | −70°C |
| UNSPSC | 12352200 |